- Nitrosamine contamination in the context of increased regulatory assessments for marketed products and new drug applications
- Nitrosamine remediation: which way to go – low nitrite excipients or addition of scavengers?
- Debating the recent challenges related to N-nitrosodimethylamine (NDMA) contamination and N-Nitrosamine drug substance-related impurities (NDSRIs). Nitrites in excipients leading to nitrosamine formation in drug product
- An update on the latest guidelines on nitrosamine risk evaluation and risk assessment. On the path to international regulatory harmonisation
